Anhedonia: Clinical Trials

131 trials for Anhedonia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

69 completed, 36 recruiting, 10 unknown, 5 terminated. 77 Not applicable, 15 Phase 2, 8 Phase 1, 7 Phase 3, 6 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable77Completed 35, Recruiting 25, Unknown 7, Not yet recruiting 3, Active not recruiting 2, Enrolling by invitation 2, Suspended 1, Terminated 1, Withdrawn 1
Phase 215Completed 10, Recruiting 2, Unknown 2, Withdrawn 1
Phase 18Completed 3, Recruiting 2, Unknown 2, Withdrawn 1
Phase 37Completed 4, Terminated 2, Recruiting 1
Phase 46Completed 4, Recruiting 2

Follow Anhedonia: new trials by email Literature Review of Anhedonia trials Research Report on Anhedonia

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Multimodal Differences in Effort-based Decision-Making in Depression
Effort-based Decision-Making Task - Depression, Anhedonia
Not applicableNot yet recruitingGeorgia Institute of Technology902027-01-012026-08-27
Clinical and Neurocomputational Effects of Behavioral Activation in Veterans With Impaired Social Functioning
Behavioral Activation (BA), Supportive Care Therapy (SCT) - Social Anhedonia, Social Function Impairment
Not applicableNot yet recruitingVA Office of Research and Development1362027-01-012026-07-16
Positive Events Training to Enhance Positive Emotions in Adolescents With Elevated Depressive Symptoms: An N=1 Trial
Positive Events Training (PET) - Emotional Distress, Anhedonia
Not applicableEnrolling by invitationKU Leuven12026-10-012026-09-17
Promoting Positive Emotions in Adolescents Using Positive Events Training: An Indicated Approach
Positive Events Training (PET) - Emotional Distress, Anhedonia
Not applicableRecruitingKU Leuven362026-10-012026-10-22
Pramipexole vs Placebo Treatment in Bipolar Disorder With Anhedonic Depression
Pramipexole, Placebo - Bipolar Disorder (BD)
Phase 3RecruitingDaniel Lindqvist1262026-10-012026-10-22
Psilocybin as a Novel Therapy for Residual Anhedonia
Psilocybin, Placebo - Anhedonia, Emotional Blunting
Phase 1RecruitingNYU Langone Health902026-09-012026-09-15
Reward Sensitivity Digital Intervention for Suicide Risk
Suicide prevention treatment - Suicidal Ideation, Suicidal
Not applicableRecruitingUniversity of Pennsylvania202026-08-212026-08-26
Efficacy of kTMP, a Novel Non-invasive Brain Stimulation Method, for the Treatment of Anhedonia
A new non-invasive brain stimulation tool, A new non-invasive brain stimulation tool with sham setting selected - Anhedonia, Major Depressive Disorder (MDD)
Not applicableNot yet recruitingMagnetic Tides1042026-07-152026-07-08
A Just-in-time Adaptive Intervention for Suicide Safety Planning in Adolescents
ViraSafe: Treatment pushes, BRITE - Suicide, Mental Health Disorder
Not applicableRecruitingKsana Health1002026-06-182026-08-12
French Minds Cohort: a French Longitudinal and Multimodal Cohort of Patients With Major Mood Disorders, Psychotic Disorders, Autism Spectrum Disorders, and Healthy Controls
3T Brain MRI, Biological Sampling, Clinical, Cognitive and Digital Assessments - Schizophrenia / Schizoaffective Disorder, First Episode Psychosis (FEP)
Not applicableRecruitingFondation FondaMental30002026-06-112026-10-19
Evaluation of Anhedonia and Emotional Eating in Individuals Using GLP-1 Receptor Agonists
Obesity, Emotional Eating
RecruitingTC Erciyes University602026-06-012026-09-03
Study on iTBS Regulating the Reward Circuit Function to Improve Anhedonia in Depression
Left DLPFC + OFC iTBS, Left DLPFC iTBS - Major Depression, Anhedonia
Not applicableRecruitingGuo Wenbin602026-05-192026-09-10
Neutralizing Interleukin (IL)-6
Tocilizumab - Major Depressive Disorder
Phase 2RecruitingIcahn School of Medicine at Mount Sinai602026-03-262026-04-29
Causal Role of Rostromedial Prefrontal Cortex for Positive Savoring in Depression
Accelerated Intermittent Theta Burst Transcranial Magnetic Stimulation - Left Rostromedial Prefrontal Cortex - Accelerated Intermittent Theta Burst, Left Dorsolateral Prefrontal Cortex - Accelerated Intermittent Theta Burst
Not applicableEnrolling by invitationFlorida State University482026-03-232026-05-20
tVNS and Approach-Avoidance Behavior in Anhedonia and Anxiety
tVNS, Sham - Healthy Participants, Anxiety Disorders (With High Anxiety Symptoms)
Not applicableRecruitingDr. Nils B. Kroemer1042026-03-232026-04-23
Investigating the Efficacy and Mechanisms of Individualized tACS Targeting Anhedonia in Late-Life Depression
Transcranial Alternating Current Stimulation (tACS), shame tACS - Late-Life Depression, Anhedonia
Not applicableRecruitingJie Li802026-03-162026-06-10
Positive Affect Treatment for Spanish-Speaking Individuals
Positive Affect Treatment - Anhedonia, Depression in Adults
Not applicableActive not recruitingSouthern Methodist University122026-01-202026-03-25
The Effect of Transcranial Direct Current Stimulation (tDCS) in Improving Emotion Health
Transcranial Direct Current Stimulation, Sham tDCS - Subthreshold Depression, Positive Emotions
Not applicableRecruitingThe University of Hong Kong902026-01-082026-05-04
Elucidating the Relevance of the Psychedelic Experience to Psilocybin's Anti-Anhedonic Effects
Psilocybin (Usona Institute), Risperidone 1 MG, MRI - Depression - Major Depressive Disorder, Anhedonia
Phase 1RecruitingMedical University of Vienna852025-11-012026-03-24
Optimizing a Just-in-time Adaptive Intervention for Suicide Safety Planning in Adolescents
ViraBrite nudges - Suicide, Mental Health Disorder
Not applicableCompletedKsana Health242025-07-162026-08-12

Showing 20 of 131. Sign in to see all of them.

Narrower conditions

Depression (65)  ·  Depressive Disorder, Major (33)  ·  Anxiety Disorders (15)  ·  Depressive Disorder (14)  ·  Bipolar Disorder (9)  ·  Mood Disorders (8)  ·  Psychotic Disorders (6)  ·  Schizophrenia (6)  ·  Suicidal Ideation (6)  ·  Suicide (6)  ·  Depressive Disorder, Treatment-Resistant (5)  ·  Mental Disorders (5)  ·  Inflammation (4)  ·  Lethargy (4)

Broader conditions

Nervous System Diseases (131)  ·  Neurobehavioral Manifestations (131)  ·  Neurologic Manifestations (131)  ·  Pathological Conditions, Signs and Symptoms (131)  ·  Signs and Symptoms (131)  ·  Mental Disorders (71)  ·  Behavior (70)  ·  Behavioral Symptoms (65)  ·  Mood Disorders (44)  ·  Depressive Disorder (33)  ·  Bipolar and Related Disorders (9)  ·  Schizophrenia Spectrum and Other Psychotic Disorders (8)  ·  Self-Injurious Behavior (8)  ·  Pathologic Processes (5)  ·  Body Weight (4)

Interventions

Aticaprant (6)  ·  Pramipexole (4)  ·  Psilocybin (4)  ·  Therapeutics (4)  ·  Transcranial Direct Current Stimulation (3)  ·  carbidopa, levodopa drug combination (3)  ·  Cognitive Behavioral Therapy (2)  ·  Dextroamphetamine (2)  ·  Endotoxins (2)  ·  Levodopa (2)  ·  Magnetic Resonance Spectroscopy (2)  ·  Transcranial Magnetic Stimulation (2)  ·  2-cyclohexylidenhydrazo-4-phenyl-thiazole (1)  ·  Bupropion (1)  ·  Buspirone (1)

Sponsors

Mclean Hospital (5)  ·  University of California, Los Angeles (5)  ·  University of North Carolina, Chapel Hill (5)  ·  Emory University (4)  ·  Janssen Research & Development, LLC (4)  ·  Region Skane (4)  ·  University of Oxford (4)  ·  Florida State University (3)  ·  Istituto Auxologico Italiano (3)  ·  Ksana Health (3)  ·  Ruhr University of Bochum (3)  ·  Anhui Medical University (2)  ·  GrayMatters Health Ltd. (2)  ·  James Murrough (2)  ·  KU Leuven (2)

Countries

United States (74)  ·  Germany (11)  ·  United Kingdom (9)  ·  Sweden (8)  ·  Belgium (7)  ·  China (7)  ·  Canada (6)  ·  Poland (6)  ·  France (5)  ·  Italy (5)  ·  Brazil (4)  ·  Bulgaria (4)  ·  Spain (4)  ·  Argentina (3)  ·  Czechia (3)

Top investigators

Diego Pizzagalli, PhD (4)  ·  Jennifer Felger, PhD (4)  ·  Catherine Harmer, DPhil (2)  ·  Filip Raes (2)  ·  Gabriel S Dichter, PhD (2)  ·  Simon E Blackwell, Dr. phil. (2)  ·  Aaron S Heller, PhD (1)  ·  Adam J Woods, Ph.D. (1)  ·  Alicia E Meuret, Ph.D. (1)  ·  Andrew D Krystal, MD, MS (1)  ·  Andrew H Miller, MD (1)  ·  Andrew M Goldfine, MD (1)  ·  Andrew M Novick, MD, PhD (1)

Results publications

PMID 36907457, PMID 37148652, PMID 38035737, PMID 38815760, PMID 39213738, PMID 42286321, PMID 19323966, PMID 19411368, PMID 26142081, PMID 30123524, PMID 30783071, PMID 32819321, PMID 33250788, PMID 33653118, PMID 33933667, PMID 35894246, PMID 35927580, PMID 36055535, PMID 36307561, PMID 36330836, PMID 36855177, PMID 37131247, PMID 37276084, PMID 37591042, PMID 38074707, PMID 38300292, PMID 38653177, PMID 39069372, PMID 39744036, PMID 39824379, PMID 40751860, PMID 41001561, PMID 41098338, PMID 41192236, PMID 41298372, PMID 41902663

NIH funding

R01MH068376 (2), R44MH135605 (2), R61MH110027 (2), 2018 (1), 2019 (1), K01AG072049 (1), K23MH108752 (1), K23MH133971 (1), K99MH126161 (1), P50MH115838 (1), R00MH126161 (1), R01AA031013 (1), R01DA031687 (1), R01MH109637 (1), R01MH119382 (1)